Prescription drugs do not affect driving abilities
the verdict
REFUTED
the evidence says no
refutedsupported
the weight of evidence
1 source for · 9 against
Multiple peer-reviewed studies and literature reviews establish that various prescription drugs, including opioids, sedatives, and psychotropics, can impair cognitive and psychomotor functions, thereby affecting driving abilities and increasing accident risks.
from this study suggest that stable opioid use does not significantly impair abilities inherent in driving (this includes physical, cognitive, and perceptual
Morphine, formerly known as morphium, is an opiate found naturally in opium, a dark brown resin produced by drying the latex of opium poppies (Papaver somniferum). It is mainly used as an analgesic (pain medication). There are multiple methods used to administer morphine: oral; sublingual; via inhalation; injection into a muscle, injection under the skin, or injection into the spinal cord area; tr
Morphine, formerly known as morphium, is an opiate found naturally in opium, a dark brown resin produced by drying the latex of opium poppies (Papaver somniferum). It is mainly used as an analgesic (pain medication). There are multiple methods used to administer morphine: oral; sublingual; via inhalation; injection into a muscle, injection under the skin, or injection into the spinal cord area; transdermal; intravenously; or via rectal suppository. It acts directly on the central nervous…
BackgroundSome psychotropic medications (e.g., benzodiazepines, sedative antidepressants, etc.) may impair cognitive and psychomotor functions and, therefore, endanger traffic safety (Ravera, Br J Clin Pharmacol, 72(3):505–513, 2011). They affect detection, registration, and information processing, problem solving, and decision-making processes, and they also affect emotional and social aspects. The objective of this research was to clarify three closely related issues that are significant for traffic safety: the prevalence of psychotropic drugs on driving, the most frequently used psychotropic drugs to treat depression, anxiety, insomnia, or any tranquilizers (whether it is a medical prescription or self-medication), and finally, provide a further understanding of the socio-demographic and psycho-social characteristics of drivers related to the psychotropic drugs consumption in Spain.MethodsA sample of 1,200 Spanish drivers ranging from 18 to 64 years was used, 666 men and 534 women were asked to answer a questionnaire composed by a set of questions structured in different sections. The only selection criteria were to be in possession of any type of driving license for vehicles other than motorcycles and drive frequently.ResultsThe results showed that 15% of the participants were consuming psychotropic drugs to treat depressive disorders, anxiety disorders, insomnia, or tranquilizers; 13.5% were using drugs to treat one of these disorders; while 1.5% used them for several of these disorders. A 2.5% of drivers were using medicines to treat depression, 2.6% to treat anxiety, and 3.7% to treat insomnia. The 8.3% of those drivers who were not using any drugs to treat these three disorders were occasionally using some type of tranquilizers. Benzodiazepines and selective serotonin reuptake inhibitors (SSRIs) were the most used type of medicines among drivers. Benzodiazepines were the most used medicines to treat anxiety, while SSRIs were the most used to treat depression, 56.5% and 43.5%, respectively.ConclusionsMeasures can be developed to reduce traffic accidents caused by the effects of these drugs; however, this will only be possible once the drivers and the use of these drugs are understood. Health care professionals and patients should be properly informed about the potential effects of some psychotropic medications on driving abilities considering individual and group differences.
<h4>Background</h4>Among individuals with schizophrenia, antipsychotic medications improve performance across several cognitive and functional domains. We sought to assess whether antipsychotic adherence reduces the risk of a motor vehicle crash.<h4>Methods</h4>We performed a case-crossover study using population-based administrative health and driving data from British Columbia, Canada. We included individuals with schizophrenia who were involved as a driver in a police-attended motor vehicle crash during a 15-year interval (2001-2016) and who filled prescriptions for antipsychotic medication as an outpatient in the 2 years before the crash. We measured adherence to antipsychotic treatment by using prescription fill data to calculate the medication possession ratio (MPR) in the 30 days before the crash (the pre-crash interval) and in a 30-day control interval ending 1 year before the crash. We used conditional logistic regression to evaluate the association between MPR and motor vehicle crash after adjusting for potential confounders.<h4>Results</h4>Among 1130 eligible motor vehicle crashes involving drivers with schizophrenia, the mean antipsychotic MPR was 0.69 in the pre-crash intervals and 0.76 in the control intervals. We found that perfect adherence to antipsychotic medication was associated with half the odds of a crash relative to complete nonadherence (adjusted odds ratio 0.50, 95% confidence interval 0.38-0.66). The findings were consistent among subgroups defined by sex, age, and history of alcohol or drug misuse.<h4>Interpretation</h4>Better adherence to antipsychotic medications was associated with lower crash risk. Physicians and fitness-to-drive policy-makers might consider antipsychotic treatment adherence as a condition for maintaining an active driver's licence among individuals with schizophrenia.
<h4>Background</h4>Motor vehicle crashes (MVCs) are a major global health concern. While alcohol continues to be a significant contributor to MVCs, the role of illicit and prescription drugs has increased in the last 4 decades. Moreover, the proliferation of new psychoactive substances (NPS) in the United States since 2010 has reshaped recreational drug use. Despite this, its contribution to MVCs has not been systematically evaluated. In this study, we report the prevalence of NPS in roadway crash victims in California.<h4>Methods</h4>Serum samples from 1000 roadway crash victims were collected and analyzed using liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF/MS) against a comprehensive database of 1314 drugs, including 1008 NPS, and quantitative analysis was performed using isotope dilution. Alcohol was quantified in an autoanalyzer using an enzymatic method employing alcohol dehydrogenase.<h4>Results</h4>Eight NPS (detection frequency = 26) were confirmed and quantified in 17 cases. Like current nationwide NPS surveillance studies, bromazolam, para-fluorofentanyl, and mitragynine were most frequently detected. NPS were detected in polypharmacy use, with traditional recreational drugs such as fentanyl, methamphetamine, and delta-9 THC most frequently co-detected. The serum geometric means detected for bromazolam (5.41 ng/mL; range: 0.22-26.59), para-fluorofentanyl (0.45 ng/mL; range: 0.28-2.02) and mitragynine (7.02; range: 0.55-90.55) were lower than those reported for overdose and death cases.<h4>Discussion</h4>This study is the first to report quantitative levels of multiple NPS and multiple NPS classes in a large US roadway crash survey, with the high detection of CNS depressants and their co-occurrence with traditional recreational drugs highlighting the need for expanded NPS testing, roadside testing strategies, and guidelines for determining drug-induced impairment; the quantitative data may be valuable in establishing these guidelines.
Road traffic injuries and drug overdoses are the two leading causes of injury death in the U.S.1 In 2017, these two mechanisms were responsible for more than 100,000 deaths. Perhaps more importantly, these two leading causes of injury are closely interconnected. Opioids and other drugs affect driving abilities (e.g., reaction time, alertness, concentration) and crash-related injuries often result in opioid prescribing,2,3 creating a potential feedback loop from crash to injury to pain to opioid use and back to crash. At any given time, about 20% of drivers have a potentially impairing drug in their system.4
Background: Driving is a coordinated psychomotor activity that involves reaction time, attention, and decision-making. Psychoactive substances such as 2-phenylethylamine (PEA) derivatives and opioids may affect these functions and contribute to traffic safety. This systematic review revealed the effects of the selected PEA derivatives and opioids on psychomotor performance among drivers and potential road safety outcomes. Methods: The review followed PRISMA 2020 standards. Using the PICO method, we conducted a systematic search in Embase, PubMed, and Web of Science (2000–2025). Included studies involved adult participants and quantified the effect of PEA derivatives or opioids on driving-related psychomotor function. Thirty-one articles, such as randomized controlled trials, crossover studies, observational studies, and simulator-based studies, were examined. Risk of bias was evaluated using the RoB2 tool. Results: Evidence indicates therapeutic amphetamine and methylphenidate doses can enhance psychomotor function and safety in patients with ADHD. Recreational or high-dose use of methamphetamine and MDMA is associated with impaired coordination, variable speed, and increased impulsivity. Opioid effects are tolerance- and dose-dependent. Small therapeutic doses of fentanyl in chronically treated patients do not notably impair driving. On the other hand, methadone and tramadol commonly cause somnolence, retardation of reaction, and increased accident risk. Conclusions: The impact of opioids and PEA derivatives on psychomotor function is multifactorial, depending on dose, time, route of administration, and patient status. These substances can either improve or impair driving safety. The findings confirm the need for individual-specific pharmacotherapy treatment. They also highlight the importance of further studies to formulate evidence-based clinical and legislative guidelines.
Cessation of driving and unsafe motor vehicle operation by dementia patients.
We surveyed 522 consecutive patients from a dementia clinic to assess duration of driving after disease onset and instances of unsafe motor vehicle operation in the preceding 6 months. Among the 333 patients licensed to drive at the onset of dementia, the median duration of driving after onset was 28.6 months. Patients with a clinical diagnosis of Alzheimer's disease drove significantly longer than those with other dementia syndromes. Of the 93 patients still driving at the time of the survey, approximately one third were reported to have had at least one form of unsafe motor vehicle operation in the past 6 months, including 21 patients with motor vehicle accidents. Motor vehicle accidents were associated with use of prescription medications with sedative properties and with lower subjective ratings of the patient's driving ability by the informant.
Published in Archives of internal medicine (1991)
of drowsy driving such as long or irregular hours or driving at night. Drug use Including some prescription drugs, over-the-counter drugs (notably antihistamines
A traffic collision, also known as a motor vehicle collision or car crash, occurs when a vehicle collides with another vehicle, pedestrian, animal, road debris, or other moving or stationary obstruction, such as a tree, boulder, pole, or structure. Traffic collisions often result in injury, disability, death, and property damage as well as financial costs to both society and the individuals involv
Drug use
Including some prescription drugs, over-the-counter drugs (notably antihistamines, opioids and muscarinic antagonists), and illegal drugs.
Distraction
Research suggests that the driver's attention is affected by distracting sounds such as conversations and operating a mobile phone while driving. Many jurisdictions now restrict or outlaw the use of some types of phones in the car. Recent research conducted by British scientists suggests that music can also have an effect; classical music is considered to be calming, yet too much could relax the driver to a condition of distraction. On the other hand, hard rock may encourage the driver to step on the acceleration pedal, thus creating a potentially dangerous situation on the road.Cell phone use is an increasingly significant problem on the roads and the U.S. National Safety Council compiled more than 30 studies postulating that hands-free is not a safer option because the brain remains distracted by the conversation and cannot focus solely on the task of driving.
your driving about narcotic addicts We are dealing with ordinary innocent people and a number of interlocking factors that spell danger These include the wide range of modern healing drugs doctors habits in administering those drugs the patients failure to pay attention to danger signs and a general lack of information about those drugs which are a serious hazard for the man at the wheel What side effects can do Few people outside the medical and pharmaceu tical professions realize how potent modem drugs can be Some prevent your blood from clotting reshuffle your body chemistry change your person ality or alter the color of your skin Others dehydrate you prevent pregnancy de sensitize your eyeballs slow down or speed up your heart beat banish your worries Such drug actions are predictable Theyre part of the result your doctor is aiming at But in addition drugs may have unpredictable side effects on some people Critically dangerous for motorists are those results predicted or unpredicted which affect your vision lower your blood pressure bring on drowsiness or make your reaction time and mental process sluggish These symptoms may come on swiftly and can affect you for an astonishing length of time
Alcohol Affect Driving? Pot Enters the Picture . 20 How Does Marijuana Affect Driving? The Accident … users — who do not know the very real dangers of driving high. And they do not know for … Driver-Impairing Illegal Drugs Driver-Impairing Prescription Drugs Legal Plus Illegal Polydrug Use The
Everything we examined (12) — 9 independent sources
This check searched the claim as stated. It did not run a separate search for evidence against it.